UK-India free trade agreement could spark pharma patent litigation
Pharmaceutical patent holders in the UK could be facing new efforts to invalidate their protections and open the door for generic medications from India, after the free trade agreement between the...To view the full article, register now.
Already a subscriber? Click here to view full article